Mereo BioPharma Group Plc
(NASDAQ) MREO
Mereo BioPharma Group Plc Financials at a Glance
Market Cap
$53.56M
Revenue (TTM)
$500.00K
Net Income (TTM)
$41.88M
EPS (TTM)
$-0.26
P/E Ratio
-1.27
Dividend
$0.00
Beta (Volatility)
1.47 (Average)
Dividend
$0.00
Beta (Volatility)
1.47 (Average)
Price
$0.34
Volume
13,644
Open
$0.33
Price
$0.34
Volume
13,644
Open
$0.33
Previous Close
$0.34
Daily Range
$0.33 - $0.34
52-Week Range
$0.20 - $3.05
Dividend
$0.00
Beta (Volatility)
1.47 (Average)
Price
$0.34
Volume
13,644
Open
$0.33
Previous Close
$0.34
Daily Range
$0.33 - $0.34
52-Week Range
$0.20 - $3.05
MREO News
MREO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Mereo BioPharma Group Plc
Industry
Biotechnology
Sector
Health CareEmployees
39
CEO
Denise Vera Scots-Knight, PhD
Website
www.mereobiopharma.comHeadquarters
London, W1G 0QF, GB
MREO Financials
Key Financial Metrics (TTM)
Gross Margin
73%
Operating Margin
-81%
Net Income Margin
-84%
Return on Equity
-83%
Return on Capital
-97%
Return on Assets
-91%
Earnings Yield
-78.74%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$53.56M
Shares Outstanding
159.13M
Volume
13.64K
Short Interest
0.00%
Avg. Volume
3.03M
Financials (TTM)
Gross Profit
$367.00K
Operating Income
$40.50M
EBITDA
$39.35M
Operating Cash Flow
$30.97M
Capital Expenditure
$20.00K
Free Cash Flow
$30.99M
Cash & ST Invst.
$40.99M
Total Debt
$202.00K
Mereo BioPharma Group Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$1.00K
+99.6%
Gross Margin
0.00%
N/A
Market Cap
$53.56M
N/A
Market Cap/Employee
$1.49M
N/A
Employees
36
N/A
Net Income
$7.35M
-5.3%
EBITDA
$6.74M
+2.5%
Quarterly Fundamentals
Net Cash
$40.79M
-35.6%
Accounts Receivable
$1.50M
-53.9%
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$202.00K
-96.8%
Return on Assets
-91.20%
N/A
Return on Invested Capital
-97.32%
N/A
Free Cash Flow
$7.68M
+18.4%
Operating Cash Flow
$7.68M
+18.5%